{"entity":{"type":"insider","cik":"0001967168","url":"/insider/0001967168","json_url":"/insider/0001967168.json","name":"Kintz Samuel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":33,"first":"2023-09-26","last":"2025-11-19","span_basis":"filed_date"},"name_variants":[{"name":"Kintz Samuel","source":"filing","n_filings":33,"first_seen":"2023-09-26","last_seen":"2025-11-19"}],"transactions":[{"id":4780603,"accession":"0001967168-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001967168-25-000008","line_url":"/filing/0001967168-25-000008#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":21.8191,"price_display":"21.82","price_state":"stated","total_value":272738.75,"total_display":"272,738.75","total_whole":"272,739","shares_owned_after":890392.0,"shares_owned_after_display":"890,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4361727,"accession":"0001967168-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001967168-25-000007","line_url":"/filing/0001967168-25-000007#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":21.3323,"price_display":"21.33","price_state":"stated","total_value":266653.75,"total_display":"266,653.75","total_whole":"266,654","shares_owned_after":902892.0,"shares_owned_after_display":"902,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-21","scope":"insider"},{"id":4899593,"accession":"0001967168-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001967168-25-000006","line_url":"/filing/0001967168-25-000006#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":20.0615,"price_display":"20.06","price_state":"stated","total_value":74227.55,"total_display":"74,227.55","total_whole":"74,228","shares_owned_after":915392.0,"shares_owned_after_display":"915,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-30","scope":"insider"},{"id":4054343,"accession":"0001967168-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001967168-25-000005","line_url":"/filing/0001967168-25-000005#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":20.03,"price_display":"20.03","price_state":"stated","total_value":56084.0,"total_display":"56,084.00","total_whole":"56,084","shares_owned_after":919092.0,"shares_owned_after_display":"919,092","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-23","filed_date":"2025-09-25","scope":"insider"},{"id":4254661,"accession":"0001967168-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001967168-25-000004","line_url":"/filing/0001967168-25-000004#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":20.25,"price_display":"20.25","price_state":"stated","total_value":20250.0,"total_display":"20,250.00","total_whole":"20,250","shares_owned_after":921892.0,"shares_owned_after_display":"921,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-19","scope":"insider"},{"id":4254659,"accession":"0001967168-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001967168-25-000004","line_url":"/filing/0001967168-25-000004#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.0946,"price_display":"19.09","price_state":"stated","total_value":95473.0,"total_display":"95,473.00","total_whole":"95,473","shares_owned_after":922892.0,"shares_owned_after_display":"922,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-19","scope":"insider"},{"id":9287361,"accession":"0001415889-25-022649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022649","line_url":"/filing/0001415889-25-022649#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1517.0,"shares_display":"1,517","price_per_share":20.0023,"price_display":"20.00","price_state":"stated","total_value":30343.4891,"total_display":"30,343.49","total_whole":"30,343","shares_owned_after":927892.0,"shares_owned_after_display":"927,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-21","scope":"insider"},{"id":4434423,"accession":"0001415889-25-022459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022459","line_url":"/filing/0001415889-25-022459#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":590.0,"shares_display":"590","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":11800.0,"total_display":"11,800.00","total_whole":"11,800","shares_owned_after":929409.0,"shares_owned_after_display":"929,409","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-20","scope":"insider"},{"id":4434420,"accession":"0001415889-25-022459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022459","line_url":"/filing/0001415889-25-022459#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10393.0,"shares_display":"10,393","price_per_share":20.0237,"price_display":"20.02","price_state":"stated","total_value":208106.3141,"total_display":"208,106.31","total_whole":"208,106","shares_owned_after":929999.0,"shares_owned_after_display":"929,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4211772,"accession":"0001415889-25-020087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-020087","line_url":"/filing/0001415889-25-020087","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":22.521428824,"price_display":"22.52","price_state":"stated","total_value":281517.8603,"total_display":"281,517.86","total_whole":"281,518","shares_owned_after":944055.0,"shares_owned_after_display":"944,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-21","scope":"insider","n_lines":3},{"id":4708130,"accession":"0001415889-25-017730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-017730","line_url":"/filing/0001415889-25-017730","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":22.183384208,"price_display":"22.18","price_state":"stated","total_value":277292.3026,"total_display":"277,292.30","total_whole":"277,292","shares_owned_after":954890.0,"shares_owned_after_display":"954,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider","n_lines":2},{"id":5039693,"accession":"0001415889-25-015785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015785","line_url":"/filing/0001415889-25-015785#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0469,"price_display":"20.05","price_state":"stated","total_value":150351.75,"total_display":"150,351.75","total_whole":"150,352","shares_owned_after":965392.0,"shares_owned_after_display":"965,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":4074817,"accession":"0001415889-25-013992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-013992","line_url":"/filing/0001415889-25-013992#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.4906,"price_display":"16.49","price_state":"stated","total_value":82453.0,"total_display":"82,453.00","total_whole":"82,453","shares_owned_after":972892.0,"shares_owned_after_display":"972,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-21","scope":"insider"},{"id":4146428,"accession":"0001415889-25-012030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-012030","line_url":"/filing/0001415889-25-012030#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":20.004,"price_display":"20.00","price_state":"stated","total_value":43408.68,"total_display":"43,408.68","total_whole":"43,409","shares_owned_after":977892.0,"shares_owned_after_display":"977,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-05","scope":"insider"},{"id":4146426,"accession":"0001415889-25-012030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-012030","line_url":"/filing/0001415889-25-012030#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5330.0,"shares_display":"5,330","price_per_share":20.0763,"price_display":"20.08","price_state":"stated","total_value":107006.679,"total_display":"107,006.68","total_whole":"107,007","shares_owned_after":980062.0,"shares_owned_after_display":"980,062","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider"},{"id":4885862,"accession":"0001415889-25-011121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-011121","line_url":"/filing/0001415889-25-011121#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.4192,"price_display":"16.42","price_state":"stated","total_value":82096.0,"total_display":"82,096.00","total_whole":"82,096","shares_owned_after":985392.0,"shares_owned_after_display":"985,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-17","filed_date":"2025-04-21","scope":"insider"},{"id":4805832,"accession":"0001415889-25-008609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008609","line_url":"/filing/0001415889-25-008609#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.8256,"price_display":"20.83","price_state":"stated","total_value":260320.0,"total_display":"260,320.00","total_whole":"260,320","shares_owned_after":990392.0,"shares_owned_after_display":"990,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":2044229,"accession":"0001415889-24-025503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-025503","line_url":"/filing/0001415889-24-025503#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":924.0,"shares_display":"924","price_per_share":30.0029,"price_display":"30.00","price_state":"stated","total_value":27722.6796,"total_display":"27,722.68","total_whole":"27,723","shares_owned_after":1002892.0,"shares_owned_after_display":"1,002,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":3237765,"accession":"0001415889-24-024991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-024991","line_url":"/filing/0001415889-24-024991","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16710.0,"shares_display":"16,710","price_per_share":28.15111669658887,"price_display":"28.15","price_state":"stated","total_value":470405.16,"total_display":"470,405.16","total_whole":"470,405","shares_owned_after":1006646.0,"shares_owned_after_display":"1,006,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-10","scope":"insider","n_lines":2},{"id":3237760,"accession":"0001415889-24-024991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024991","line_url":"/filing/0001415889-24-024991","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13267.0,"shares_display":"13,267","price_per_share":27.95878632697671,"price_display":"27.96","price_state":"stated","total_value":370929.2182,"total_display":"370,929.22","total_whole":"370,929","shares_owned_after":1020626.0,"shares_owned_after_display":"1,020,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-10","scope":"insider","n_lines":2},{"id":3000788,"accession":"0001415889-24-024901","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024901","line_url":"/filing/0001415889-24-024901#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2730.0,"shares_display":"2,730","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":75075.0,"total_display":"75,075.00","total_whole":"75,075","shares_owned_after":1033793.0,"shares_owned_after_display":"1,033,793","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-07","filed_date":"2024-10-08","scope":"insider"},{"id":3000785,"accession":"0001415889-24-024901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024901","line_url":"/filing/0001415889-24-024901#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12206.0,"shares_display":"12,206","price_per_share":27.5104,"price_display":"27.51","price_state":"stated","total_value":335791.9424,"total_display":"335,791.94","total_whole":"335,792","shares_owned_after":1036523.0,"shares_owned_after_display":"1,036,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-04","filed_date":"2024-10-08","scope":"insider"},{"id":2930277,"accession":"0001415889-24-024671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024671","line_url":"/filing/0001415889-24-024671#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":526.0,"shares_display":"526","price_per_share":27.5371,"price_display":"27.54","price_state":"stated","total_value":14484.5146,"total_display":"14,484.51","total_whole":"14,485","shares_owned_after":1048729.0,"shares_owned_after_display":"1,048,729","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider"},{"id":2132682,"accession":"0001415889-24-022512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-022512","line_url":"/filing/0001415889-24-022512#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":22.8932,"price_display":"22.89","price_state":"stated","total_value":274718.4,"total_display":"274,718.40","total_whole":"274,718","shares_owned_after":1049255.0,"shares_owned_after_display":"1,049,255","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":2756166,"accession":"0001415889-24-020687","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-020687","line_url":"/filing/0001415889-24-020687#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2270.0,"shares_display":"2,270","price_per_share":27.5573,"price_display":"27.56","price_state":"stated","total_value":62555.071,"total_display":"62,555.07","total_whole":"62,555","shares_owned_after":1061255.0,"shares_owned_after_display":"1,061,255","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-31","filed_date":"2024-08-02","scope":"insider"},{"id":2279178,"accession":"0001415889-24-020265","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-020265","line_url":"/filing/0001415889-24-020265","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":24.922718675,"price_display":"24.92","price_state":"stated","total_value":299072.6241,"total_display":"299,072.62","total_whole":"299,073","shares_owned_after":1063568.0,"shares_owned_after_display":"1,063,568","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-29","scope":"insider","n_lines":3},{"id":2330299,"accession":"0001415889-24-018336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-018336","line_url":"/filing/0001415889-24-018336","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.658462033333333,"price_display":"21.66","price_state":"stated","total_value":259901.5444,"total_display":"259,901.54","total_whole":"259,902","shares_owned_after":1076103.0,"shares_owned_after_display":"1,076,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-27","scope":"insider","n_lines":2},{"id":2806390,"accession":"0001415889-24-014915","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-014915","line_url":"/filing/0001415889-24-014915","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.184170566666666,"price_display":"23.18","price_state":"stated","total_value":278210.0468,"total_display":"278,210.05","total_whole":"278,210","shares_owned_after":5319.0,"shares_owned_after_display":"5,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider","n_lines":3},{"id":2602179,"accession":"0001415889-24-011707","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-011707","line_url":"/filing/0001415889-24-011707#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":16.8917,"price_display":"16.89","price_state":"stated","total_value":202700.4,"total_display":"202,700.40","total_whole":"202,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-25","filed_date":"2024-04-29","scope":"insider"},{"id":2999539,"accession":"0001415889-24-010828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010828","line_url":"/filing/0001415889-24-010828#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47709.0,"shares_display":"47,709","price_per_share":25.0414,"price_display":"25.04","price_state":"stated","total_value":1194700.1526,"total_display":"1,194,700.15","total_whole":"1,194,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-15","scope":"insider"},{"id":2069451,"accession":"0001415889-24-009220","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-009220","line_url":"/filing/0001415889-24-009220","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":17.555093,"price_display":"17.56","price_state":"stated","total_value":210661.116,"total_display":"210,661.12","total_whole":"210,661","shares_owned_after":4671.0,"shares_owned_after_display":"4,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-27","scope":"insider","n_lines":2},{"id":2039536,"accession":"0001415889-24-005748","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-005748","line_url":"/filing/0001415889-24-005748","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":16.8877866,"price_display":"16.89","price_state":"stated","total_value":202653.4392,"total_display":"202,653.44","total_whole":"202,653","shares_owned_after":4376.0,"shares_owned_after_display":"4,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-28","scope":"insider","n_lines":2},{"id":2037802,"accession":"0001209191-24-002392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-002392","line_url":"/filing/0001209191-24-002392","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":15.68579135,"price_display":"15.69","price_state":"stated","total_value":188229.4962,"total_display":"188,229.50","total_whole":"188,229","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider","n_lines":2},{"id":8548494,"accession":"0001209191-23-059908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059908","line_url":"/filing/0001209191-23-059908#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":14.6424,"price_display":"14.64","price_state":"stated","total_value":175708.8,"total_display":"175,708.80","total_whole":"175,709","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8681887,"accession":"0001209191-23-059717","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-059717","line_url":"/filing/0001209191-23-059717#line-4","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8175.0,"shares_display":"8,175","price_per_share":13.0465,"price_display":"13.05","price_state":"stated","total_value":106655.1375,"total_display":"106,655.14","total_whole":"106,655","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-26","scope":"insider"},{"id":8681880,"accession":"0001209191-23-059717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059717","line_url":"/filing/0001209191-23-059717#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":260.0,"total_display":"260.00","total_whole":"260","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider"},{"id":8044961,"accession":"0001209191-23-059433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059433","line_url":"/filing/0001209191-23-059433#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967168","owner_name":"Kintz Samuel","owner_display_name":"Kintz Samuel","owner_url":"/insider/0001967168","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7779.0,"shares_display":"7,779","price_per_share":13.0143,"price_display":"13.01","price_state":"stated","total_value":101238.2397,"total_display":"101,238.24","total_whole":"101,238","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-21","scope":"insider"}],"collapsed":true,"next_cursor":"2023-12-20|8044961","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":52,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":33,"first_seen":"2023-09-26","last_seen":"2025-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001967168","retrieved_at":"2026-08-26T13:18:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}